Medical Decision Modeling (United States)
- Research works
- 89 ▲ 14% vs 2018-21
- Citations
- 2.1k 24.2 per fractional work
- Top-10% rate
- 8.1% all institutions 10.0%
- Open access
- 40% world 40%
- International
- 27% world 18%
Not ranked overall: Medical Decision Modeling (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Medical Decision Modeling (United States) work in?
In all years, 58% of research at Medical Decision Modeling (United States) is in Health Sciences, 20% in Social Sciences. Its largest fields are Medicine (54%), Economics, Econometrics and Finance (13%), Engineering (7%). It does 2.3× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 23 fields, with their numbers
- Health Sciences5258.2%
- Medicine4853.7%
- Health Professions22.8%
- Dentistry11.2%
- Veterinary00.3%
- Nursing00.3%
- Social Sciences1719.5%
- Physical Sciences1315.2%
- Engineering66.6%
- Mathematics44.2%
- Materials Science21.7%
- Computer Science11.2%
- Chemistry10.7%
- Physics and Astronomy00.4%
- Environmental Science00.4%
- Life Sciences67.0%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 6.9×. Every wedge is a field page.
All 18 fields, with their numbers
- Economics, Econometrics and Finance6.87×3 works
- Veterinary6.48×0 works
- Medicine2.32×8 works
- Materials Science2.20×2 works
- Immunology and Microbiology1.84×0 works
- Biochemistry, Genetics and Molecular Biology1.37×1 works
- Pharmacology, Toxicology and Pharmaceutics1.00×0 works
- Health Professions0.98×0 works
- Neuroscience0.63×0 works
- Social Sciences0.58×1 works
- Chemistry0.50×0 works
- Physics and Astronomy0.40×0 works
- Engineering0.39×1 works
- Mathematics0.30×0 works
- Computer Science0.25×0 works
- Business, Management and Accounting0.20×0 works
- Environmental Science0.18×0 works
- Psychology0.13×0 works
- Economics, Econometrics and Finance 6.9×
- Veterinary 6.5×
- Medicine 2.3×
- Materials Science 2.2×
- Immunology and Microbiology 1.8×
- Biochemistry, Genetics and Molecular Biology 1.4×
- Pharmacology, Toxicology and Pharmaceutics 1.0×
- Health Professions 1.0×
- Neuroscience 0.6×
- Social Sciences 0.6×
- Chemistry 0.5×
- Physics and Astronomy 0.4×
- Engineering 0.4×
- Mathematics 0.3×
- Computer Science 0.2×
- Business, Management and Accounting 0.2×
- Environmental Science 0.2×
- Psychology 0.1×
Who are the top researchers at Medical Decision Modeling (United States)?
Ranked on the quality score, Katherine A. Weimer, Julie A. Myers and Kari A. Kelton lead among researchers whose main affiliation is Medical Decision Modeling (United States).
- 1
Katherine A. Weimer
United States · #1,126,583 worldwide 1.4k citations · 15 works
- 2
Julie A. Myers
United States · #2,407,034 worldwide 382 citations · 15 works
- 3
Kari A. Kelton
United States · #2,416,977 worldwide 282 citations · 16 works
- 4
Ronald C. Wielage
United States · #2,461,256 worldwide 464 citations · 23 works
- 5
Sinem Perk
United States · #2,550,867 worldwide 607 citations · 37 works
- 6
RW Klein
United States · #3,443,237 worldwide 6 citations · 15 works
- 7
James C. Gahn
United States · #3,541,562 worldwide 204 citations · 20 works
- 8
Megha Bansal
United States · #3,719,122 worldwide 515 citations · 45 works
- 9
H.J. Smolen
United States · #4,072,354 worldwide 8 citations · 20 works
- 10
Nicolas M. Furiak
United States · #4,149,618 worldwide 240 citations · 18 works
Which keywords describe research at Medical Decision Modeling (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Glycemic Control, Insulin Therapy, Metabolic Syndrome, Complications and Cardiovascular Disease.
- Type 2 Diabetes
- Cardiovascular Outcomes
- Molecular Characterization
- Bayesian Methods
- Primary Care
- Autoantibodies
- Chemotherapy
- Financial Toxicity
- Clinical Guidelines
- Biomarkers
- Continuous Glucose Monitoring
- Cardiovascular Risk
- Risk Factors
- Headache Disorders
- Diabetes
- Complications
- Inflammation
- Glycemic Control
- Epidemiology
- Cost-effectiveness Analysis
- Quality of Life
- Health Utility Measures
- Cardiovascular Disease
- Insulin Therapy
- Metabolic Syndrome
- Neurological Disorders
- Genetic Influences
- Migraine
- Clinical Trials
- Targeted Therapy
- Hypoglycemia
- Hypertension
- Cost of Care
- Heart Failure
- Guidelines
- Treatment Guidelines
- 3D Printing
- Breast Cancer
- Adaptive Designs
- False Discovery Rate
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Quality of Life9▲ 7.2×11 topics
- Cost-effectiveness Analysis6▲ 91×1 topic
- Health Utility Measures6▲ 91×1 topic
- Epidemiology6▲ 1.61×31 topics
- Cardiovascular Disease4▲ 4.4×8 topics
- Glycemic Control4▲ 36×4 topics
- Insulin Therapy4▲ 45×3 topics
- Inflammation4▲ 2.0×15 topics
- Metabolic Syndrome4▲ 5.5×10 topics
- Complications4▲ 8.0×5 topics
- Neurological Disorders4▲ 5.9×4 topics
- Diabetes3▲ 7.5×4 topics
- Genetic Influences3▲ 62×2 topics
- Headache Disorders3▲ 145×1 topic
- Migraine3▲ 80×1 topic
- Risk Factors3▲ 3.3×10 topics
- Clinical Trials3▲ 5.2×9 topics
- Cardiovascular Risk3▲ 9.0×6 topics
- Targeted Therapy3▲ 14×3 topics
- Continuous Glucose Monitoring3▲ 66×1 topic
- Hypoglycemia3▲ 66×1 topic
- Biomarkers2▲ 4.4×6 topics
- Hypertension2▲ 7.7×4 topics
- Clinical Guidelines2▲ 8.4×3 topics
- Cost of Care2▲ 137×1 topic
- Financial Toxicity2▲ 137×1 topic
- Heart Failure2▲ 5.7×5 topics
- Chemotherapy2▲ 3.5×7 topics
- Guidelines2▲ 5.3×4 topics
- Autoantibodies2▲ 9.9×2 topics
- Treatment Guidelines2▲ 10×3 topics
- Primary Care2▲ 5.0×6 topics
- 3D Printing2▲ 11×2 topics
- Bayesian Methods2▲ 35×2 topics
- Breast Cancer2▲ 7.2×6 topics
- Molecular Characterization2▲ 9.8×3 topics
- Adaptive Designs2▲ 69×1 topic
- Cardiovascular Outcomes2▲ 41×1 topic
- False Discovery Rate2▲ 69×1 topic
- Type 2 Diabetes2▲ 9.4×1 topic
Which research topics does Medical Decision Modeling (United States) publish most on?
By volume in 2022-now: Chronic Lymphocytic Leukemia Research, Health Systems, Economic Evaluations, Quality of Life, Economic and Financial Impacts of Cancer and Advanced Breast Cancer Therapies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 3 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
- 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
- 6 Machine Learning in Materials Science Materials Chemistry 1 works
- 7 Chronic Myeloid Leukemia Treatments Hematology 0 works
- 8 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
- 9 Smoking Behavior and Cessation Physiology 0 works
- 10 Urinary Bladder and Prostate Research Urology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Medical Decision Modeling (United States)'s research output changed?
Output in 2022-2025 was 14% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Medical Decision Modeling (United States) as a percentage of every work published that year, 0.000054% in 2024.
Fractional works of Medical Decision Modeling (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Indianapolis
- Eli Lilly (United States)
- University of Indianapolis
- Butler University
- Indiana University Health
- Indianapolis Zoo
- Martin University
- Regenstrief Institute
- Marian University - Indiana
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Medical Decision Modeling (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.